Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allient Inc. stock logo
ALNT
Allient
$34.28
-1.4%
$26.26
$16.91
$35.13
$580.33M1.47116,520 shs140,267 shs
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$3.36
-2.3%
$3.30
$2.37
$7.63
$425.57M1.26798,724 shs846,772 shs
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
$8.86
+0.6%
$6.44
$3.91
$13.99
$609.67M1.61817,927 shs790,408 shs
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
$3.61
-4.0%
$2.80
$0.58
$4.04
$158.23M1.33193,330 shs69,639 shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allient Inc. stock logo
ALNT
Allient
+2.12%+9.48%+16.42%+52.28%+32.89%
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-0.86%+1.18%+13.91%-16.91%-45.91%
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
-4.34%+7.44%+50.60%+28.99%-6.48%
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
+4.74%+5.32%+28.77%+64.91%+382.05%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Allient Inc. stock logo
ALNT
Allient
2.9856 of 5 stars
1.33.01.70.04.12.52.5
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
2.1588 of 5 stars
3.12.00.00.01.74.20.0
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
2.4634 of 5 stars
3.52.00.00.04.01.70.0
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
2.2406 of 5 stars
2.04.00.00.03.72.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Allient Inc. stock logo
ALNT
Allient
2.50
Moderate Buy$31.00-9.57% Downside
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
2.20
Hold$5.6066.67% Upside
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
3.00
Buy$25.38186.40% Upside
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
4.00
Strong Buy$8.00121.61% Upside

Current Analyst Ratings Breakdown

Latest RPID, EYPT, ALNT, and CTKB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/29/2025
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$22.00
5/28/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$9.00 ➝ $7.00
5/16/2025
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$30.00 ➝ $26.00
5/12/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSell ➝ Sell$3.50 ➝ $3.00
5/9/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$4.00
5/8/2025
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$33.00 ➝ $27.00
5/5/2025
Allient Inc. stock logo
ALNT
Allient
Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$35.00
5/5/2025
Allient Inc. stock logo
ALNT
Allient
Northland Capmk
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
5/5/2025
Allient Inc. stock logo
ALNT
Allient
Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
3/19/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$6.00 ➝ $6.00
(Data available from 6/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Allient Inc. stock logo
ALNT
Allient
$516.06M1.12$5.00 per share6.86$15.52 per share2.21
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$197.05M2.16$0.02 per share206.16$2.90 per share1.16
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
$56.04M10.88N/AN/A$5.66 per share1.57
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
$29.65M5.34N/AN/A$2.78 per share1.30
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Allient Inc. stock logo
ALNT
Allient
$24.10M$0.5938.9518.73N/A2.64%10.80%4.75%8/6/2025 (Estimated)
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$12.15M-$0.09N/AN/A-5.05%-2.58%-2.05%8/5/2025 (Estimated)
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
-$70.79M-$2.41N/AN/AN/A-226.57%-43.01%-31.63%8/6/2025 (Estimated)
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
-$52.47M-$1.03N/AN/AN/A-184.93%-48.05%-39.18%8/1/2025 (Estimated)

Latest RPID, EYPT, ALNT, and CTKB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2025Q1 2025
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
-$0.27-$0.26+$0.01-$0.26$6.63 million$7.21 million
5/8/2025Q1 2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$0.04-$0.09-$0.05-$0.09$43.18 million$41.46 million
5/7/2025Q1 2025
Allient Inc. stock logo
ALNT
Allient
$0.33$0.46+$0.13$0.21$125.00 million$134.62 million
5/7/2025Q1 2025
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
-$0.65-$0.65N/A-$0.65$8.84 million$24.50 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Allient Inc. stock logo
ALNT
Allient
$0.120.35%+4.55%20.34%N/A
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/AN/AN/AN/AN/A
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
N/AN/AN/AN/AN/A
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
N/AN/AN/AN/AN/A

Latest RPID, EYPT, ALNT, and CTKB Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/7/2025
Allient Inc. stock logo
ALNT
Allient
quarterly$0.030.4%5/22/20255/22/20256/5/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Allient Inc. stock logo
ALNT
Allient
0.85
4.10
2.18
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/A
6.21
5.47
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
N/A
5.50
5.45
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
N/A
5.52
4.19

Institutional Ownership

CompanyInstitutional Ownership
Allient Inc. stock logo
ALNT
Allient
61.57%
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
69.46%
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
99.41%
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
52.60%

Insider Ownership

CompanyInsider Ownership
Allient Inc. stock logo
ALNT
Allient
15.60%
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
10.33%
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
4.46%
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
29.96%
CompanyEmployeesShares OutstandingFree FloatOptionable
Allient Inc. stock logo
ALNT
Allient
1,95016.93 million14.22 millionOptionable
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
500126.66 million116.45 millionOptionable
EyePoint Pharmaceuticals, Inc. stock logo
EYPT
EyePoint Pharmaceuticals
12068.81 million65.02 millionOptionable
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
20043.83 million29.95 millionNot Optionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Allient stock logo

Allient NASDAQ:ALNT

$34.28 -0.47 (-1.35%)
As of 04:00 PM Eastern

Allient Inc., together with its subsidiaries, designs, manufactures, and sells precision and specialty controlled motion components and systems for various industries in the United States, Canada, South America, Europe, and Asia-Pacific. It offers brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers, optical encoders, active and passive filters, input/output modules, industrial communications gateways, light-weighting technologies, and other controlled motion-related products, as well as nano precision positioning systems, servo control systems, and digital servo amplifiers and drives. The company sells its products to end customers and original equipment manufacturers in vehicle, medical, aerospace and defense, and industrial markets through direct sales force, authorized manufacturers' representatives, and distributors. The company was formerly known as Allied Motion Technologies Inc. and changed its name to Allient Inc. in August 2023. Allient Inc. was incorporated in 1962 and is headquartered in Amherst, New York.

Cytek Biosciences stock logo

Cytek Biosciences NASDAQ:CTKB

$3.36 -0.08 (-2.33%)
As of 04:00 PM Eastern

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

EyePoint Pharmaceuticals stock logo

EyePoint Pharmaceuticals NASDAQ:EYPT

$8.86 +0.05 (+0.57%)
As of 04:00 PM Eastern

EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

Rapid Micro Biosystems stock logo

Rapid Micro Biosystems NASDAQ:RPID

$3.61 -0.15 (-3.99%)
As of 04:00 PM Eastern

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.